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Abstract 
AIM: Grapefru i t-seed extract (GSE) conta in ing 
flavonoids, possesses antibacterial and antioxidative 
properties but whether it influences the gastric defense 
mechanism and gastroprotection against ethanol- and 
stress-induced gastric lesions remains unknown. 
METHODS: We compared the effects of GSE on 
gastric mucosal lesions induced in rats by topical 
app l icat ion of 100% ethanol or 3 .5 h of water 
immersion and restraint stress (WRS) with or without 
(A) inhibition of cyclooxygenase (COX)-1 activity by 
indomethacin and rofecoxib, the selective COX-2 
inhibitor, (B) suppression of NO-synthase with L-NNA
(20 mg/kg ip), and (C) inactivation by capsaicin
(125 mg/kg sc) of sensory nerves with or without 
intragastric (ig) pretreatment with GSE applied 30 min 
prior to ethanol or WRS. One hour after ethanol and 3.5 h 
after the end of WRS, the number and area of gastric 
lesions were measured by planimetry, the gastric blood 
flow (GBF) was assessed by H2-gas clearance technique 
and plasma gastrin levels and the gastric mucosal 
generation of PGE2, superoxide dismutase (SOD) activity 
and malonyldialdehyde (MDA) concentration, as an index 
of lipid peroxidation were determined. 
RESULTS: Ethanol and WRS caused gastric lesions 
accompanied by the significant fall in the GBF and 
SOD activity and the rise in the mucosal MDA content. 
Pretreatment wi th GSE (8-64 mg/kg i g) dose-
dependently attenuated gastric lesions induced by 100% 
ethanol and WRS; the dose reducing these lesions by 
50% (ID50) was 25 and 36 mg/kg, respectively, and this 
protective effect was similar to that obtained with methyl 
PGE2 analog (5 μg/kg i g). GSE significantly raised the 
GBF, mucosal generation of PGE2, SOD activity and 
plasma gastrin levels while attenuating MDA content. 
Inhibition of PGE2 generation with indomethacin or 
rofecoxib and suppression of NO synthase by L-NNA 
or capsaicin denervation reversed the GSE-induced 
protection and the accompanying hyperemia. Co-
treatment of exogenous calcitonine gene-related 
peptide (CGRP) with GSE restored the protection and 
accompanying hyperemic effects of GSE in rats with 
capsaicin denervation. 
CONCLUSION: GSE exerts a potent gastroprotective 
activity against ethanol and WRS-induced gastric 
lesions via an increase in endogenous PG generation, 
suppression of lipid peroxidation and hyperemia possibly 
mediated by NO and CGRP released from sensory 
nerves.
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Gastric blood flow; Superoxide dismutase; Prostaglandin; 
Calcitonine gene-related peptide 
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INTRODUCTION 
Grapefruit-seed extract (GSE) containing flavonoids, 
possesses antibacterial, antiviral and antifungal properties[1-3]. 
These beneficial actions of  GSE have been attributed to 
the antioxidative activity of  grapefruit containing citrous 
flavonoids such as naringenin[4]. Moreover, grapefruit juice 
and its major flavonoid exhibited the potent anti-H pylori 
activity in vitro[5] and was also recently found to exert the 
cytoprotection against hepatocyte injury induced by algal 
toxins[6]. In another study, naringenin showed anti-cancer 
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activity against human breast cancers[7].  Therapeutic 
efficacy of  citrous fruits such as grapefruits and red grapes 
has been explained by the content of  different classes 
of  polyphenolic flavonoids, that were shown to inhibit 
platelet aggregation, thus decreasing the risk of  coronary 
thrombosis and myocardial infarction[8].  However, the 
involvement of  grapefruit extracts containing various 
flavonoids in the mechanism of  gastric mucosal defense 
has been little studied. 
Our group demonstrated previously that other 
flavonoids, namely, meciadanol, a synthetic flavonoid 
inhibiting histidine decarboxylase (HDC) and decreasing 
histamine content in the stomach, attenuated gastric 
mucosal lesions produced by ethanol and aspirin via 
the mechanism unrelated to gastric acid secretion 
and endogenous prostaglandins (PG)[9]. Furthermore, 
naringenin, a major citrous flavonoid, was reported 
to exhibit gastroprotection against the gastric injury 
induced by absolute ethanol due to the increase in the 
mucus secretion and that this gastroprotective effect 
of  naringenin and accompanying increase in the mucus 
secretion, were, in part, attenuated by indomethacin 
suggesting the involvement of  endogenous PG in the 
mechanism of  this flavonoid-induced gastroprotection[10]. 
It remains unknown, to what extent GSE influences 
the gastric mucosal injury induced by topical (ethanol) 
and non-topical ulcerogens (stress) and, if  so, what is 
the mechanism of  gastroprotection induced by GSE. 
Therefore, using animal models of  gastric lesions induced 
by 100% ethanol and water immersion and restraint stress 
(WRS), we determined the influence of  GSE on gastric 
lesions and the accompanying changes in the gastric blood 
flow (GBF) in the rat stomach.  An attempt was also made 
to assess the contribution of  gastric acid secretion, plasma 
gastrin levels, PG/cyclooxygenase (COX)-system, nitric 
oxide (NO) and sensory nerves in the gastroprotective 
effect of  GSE.  Finally, we evaluated the effect of  
pretreatment with GSE on the gene expression and activity 
of  superoxide dismutase (SOD) and lipid peroxidation, as 
expressed by malonyldialdehyde (MDA) concentration, in 
rats with or without the pretreatment with GSE.    
  
MATERIALS AND METHODS
Male Wistar rats, weighing 180-220 g and fasted for 24 h
before the study were employed in all the studies. This 
study was approved by the Institutional Animal Care 
and Use Committee of  Jagellonian University School 
of  Medicine in Cracow and run in accordance to the 
statements of  European Union regarding handling of  
experimental animals.
Gastric secretory studies 
The effects of  GSE purchased from Herb-Pharma, Welke 
Dudince, Slovakia on gastric acid secretion were examined 
in 40 conscious rats equipped about 1 mo earlier with a 
gastric fistula (GF) as described previously[11]. The animals 
were fasted overnight but had free access to water 24 h 
before the experiment and they were placed in individual 
Bollman type cages to maintain the minimum restraint 
necessary.  The GF was opened; the stomach was rinsed 
gently with about 5 mL of  tap water at 37 ℃. The basal 
gastric secretion was collected for 60 min and GSE was 
administered i.g. in gradual doses ranging from 8  to 64mg/kg,
each dose being administered on a separate test day.  In 
control tests, vehicle (1 mL of  saline, i g) was given in the 
same volume as in tests with GSE and the collection of  
gastric juice was continued for the final 120 min. The volume 
and acid concentration of  each collected sample of  gastric 
juice were measured and acid outputs was calculated and 
expressed in terms of  micromoles of  acid per 30 min[12].
Induction of ethanol and stress lesions and determination 
of gastric blood flow (GBF)
Acute gastric lesions were induced by an intragastric (ig)
application of  100% ethanol similarly to the method 
described previously[11,12].  Briefly, 100% ethanol in a 
volume of  1.5 mL was administered ig to rats by means 
of  a metal orogastric tube.  After 60 min, the animals 
were lightly anesthetized with ether, their abdomen was 
opened by the midline incision and stomach exposed for 
the measurement of  GBF by means of  using the H2-
gas clearance technique as described previously[13].  For 
this purpose double electrodes of  electrolytic regional 
blood flowmeter (Biotechnical Science, Model RBF-2, 
Osaka, Japan) were inserted into the gastric mucosa.  One 
of  these electrodes was used for the local generation of  
gaseous H2 and another for the measurement of  tissue H2.
With this method, the H2 generated locally was carried 
out by flow of  blood, while the polarographic current 
detector reads out decreasing tissue H2. The tissue H2 
clearance curve was used to calculate an absolute flow 
rate (mL/100 g/min) in the oxyntic area as described 
previously[13].  The measurements were made in three areas 
of  the mucosa and the mean values of  the measurements 
were calculated and expressed as percent changes of  those 
recorded in the vehicle (saline) treated animals. After the 
GBF measurement, the stomach was removed, rinsed with 
water and pinned open for macroscopic examination.  The 
area of  necrotic lesions in oxyntic mucosa was determined 
by computerized planimetry (Morphomat, Carl Zeiss, 
FRG)[12-14] by the person who did not know to which 
experimental group the animals belonged.   
The WRS was induced in the animals that were placed 
in restraint cages and immersed vertically to the level of  
the xiphoid process in a water bath of  23 ℃ for 3.5 h[13,14]. 
After 3.5 h of  WRS, the rats were lightly anesthetized 
with ether, the abdomen was opened and the stomach was 
exposed.  The GBF was measured in the oxyntic gland area 
of  the stomach by means of  local H2-gas clearance method 
using an electrolytic regional blood flow meter (Biomedical 
Science, Model RBF-2, Osaka, Japan) as described above. 
The stomach was removed, opened along the greater 
curvature and placed flat to count the number of  gastric 
lesions by two investigators, unaware of  the treatment 
given as described in our previous studies[13,14]. The stress 
lesions were defined as round or linear mucosal defects of  
at least 0.1 mm in diameter. 
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Animals with sensory denervation induced by capsaicin 
The role of  sensory afferent nerves in mechanism of  
WRS-induced gastric lesions with or without pretreatment 
with GSE was determined in rats with or without capsaicin 
induced deactivation of  these nerves.  For this purpose 
the animals were pretreated with capsaicin (Sigma Co., 
St. Louis, MO, USA) injected s.c. for 3 consecutive days 
at a dose of  25, 50 and 50 mg/kg for about 2 wk, before 
the experiment[15,16]. All injections of  capsaicin were 
performed under ether anesthesia to counteract the pain 
reactions and respiratory impairment associated with 
injection of  this agent.  To check the effectiveness of  the 
capsaicin denervation, a drop of  0.1 mg/mL solution of  
capsaicin was instilled into the eye of  each rat and the 
protective counting movements were counted as described 
previously[16]. Rats with or without capsaicin-denervation 
received vehicle or GSE (5-80 mg/kg ig) 30 min prior to 
exposure to 3.5 h of  WRS. At the end of  WRS, animals 
were anesthetized and then the GBF and the number 
of  gastric lesions were measured in a similar manner as 
mentioned above.  
Determination of mucosal generation of PGE2, lipid 
peroxidation and SOD activity in gastric mucosa exposed 
to ethanol and WRS with and without GSE  
In groups of  rats exposed to standard 3.5 h of  WRS 
without or with pretreatment with GSE, the mucosal 
samples from the gastric mucosa were taken by biopsy 
(about 200 mg) from oxynt ic g land area without 
mucosal lesions immediately after the animals were 
killed to determine the mucosal generation of  PGE2 by 
radioimmunoassay (RIA) as described previously[17]. The 
capability of  the mucosa to generate PGE2 was expressed 
in nanograms of  wet tissue weight.
Since lipid peroxidation is a well-established mechanism 
of  cellular injury induced by reactive oxygen metabolites, 
we measured the changes in the MDA as an indicator of  
this lipid peroxidation in gastric mucosa[18,19] exposed to 
WRS without and with the treatment with GSE.  For the 
measurement of  lipid peroxidation, the tissue was weighed, 
transferred to the ice-cooled test tube and homogenized 
in 400 μL of  20 m mol/L Tris buffer pH 7.4 containing 
5 mM butylated hydroxytoluene to prevent new lipid 
peroxidation that can occur during the homogenization. 
The homogenate was then centrifuged at 4 oC for 10 min 
and resulted supernatant (200 μL) was stored in -80 oC 
until an assay of  lipid peroxidation. The content of  lipid 
peroxidation was measured at 37 oC by spectrophotometer 
at a wave length of  586 nm and compared with the 
absorbance of  purified MDA as the standard.
The activity of  SOD was measured in the gastric 
mucosa of  rats exposed to WRS with or without 
pretreatment with GSE using SOD 525 assay kit (OXIS 
International, Inc., Portland, USA)[19,20].  The gastric tissue 
was first washed with 0.9% NaCl containing 0.16 mg/mL 
heparin to remove red blood cells which may interfere 
with the SOD activity in the gastric specimens.  Then the 
biopsy sample was blotted on the filter paper, weighed 
and finally homogenized in 400 μL of  PBS buffer pH 7.4 
using a tissuemizer Ultra Turax (Janke and Kunkel GmbH 
and Co., Staufen, Germany). The principle of  the SOD 
measurement is based on the SOD-mediated increase in 
the rate of  auto-oxidation of  5, 6, 6a, 11β-tetrahydro-
3,9,10-trihydrobenzoflurene in aqueous solution at 37 oC 
to yield a chromophore with maximum absorbance at 525 
nm.  Ethanol-chloroform extraction was employed to 
inactivate Mn-SOD and Fe-SOD and to ensure that the 
assay is specific for Cu/Zn-SOD.  
Determination of SOD transcripts by reverse transcriptase 
polymerase chain reaction (RT-PCR)  
The expression of  SOD was determined by RT-PCR in 
the gastric mucosa of  intact rats or following exposure 
to WRS with or without GSE.  Samples of  the gastric 
oxyntic mucosa (about 500 mg) were scraped off  on 
ice using glass slide and then immediately snap frozen 
in liquid nitrogen, and stored at -80 oC. Total RNA was 
isolated from the gastric oxyntic mucosa using a rapid 
guanidinum isothiocyanate/phenol chloroform single 
step extraction kit from Stratagene (Stratagene GmbH, 
Heidelberg, Germany)[21,22].  Following precipitation, the 
RNA was resuspended in RNase-free TE buffer and the 
concentration was estimated by absorbance at 260 nm 
wave length. Samples were frozen at -80 oC until analysis. 
First strand cDNA was synthesized from total 
cellular RNA (5 µg) using 200 U Strata Script TM reverse 
transcriptase (Stratagene GmbH, Heidelberg, Germany) 
and oligo (dT) primers (Stratagene GmbH, Heidelberg, 
Germany). After the reverse transcription, the transcriptase 
activity was destroyed by heating, and the cDNA was 
stored at -20 oC until PCR. 
A 496-bp fragment of  SOD was amplified from 
single-stranded DNA by PCR using two oligonucleotide 
pr imers to SOD. The SOD sense pr imer was 5 ’
CGAGTTATGGCGACGAAG3’ and antisense primer 
was 5’GTCAGCAGTCACATTGCC3’.  The primers for 
SOD and β-actin were synthesized by Biometra (Gottingen, 
Germany). Concomitantly, amplification of  control rat 
β-actin (Clon Tech, Palo Alto, CA, USA) (764 bp) was 
performed on the same samples to verify RNA integrity.  
DNA amplification was carried out under the following 
conditions; denaturation at 94 oC for 1 min, annealing at
60 oC for 45 s, and extension at 72 oC for 45 s. The 
number of  amplification cycles was 29 for SOD. Each 
PCR-product (8 µL) was electrophoresed on 1.5% agarose 
gel stained with ethidium bromide, and then visualized 
under UV light.  Location of  predicted PCR product was 
confirmed by using a 100-bp ladder (Gibco BRL/Life 
Technologies, Eggenstein, Germany) as standard marker.
The intensity of  bands was quantified in a semi-
quantitative manner using densitometry (LKB Ultrascan, 
Pharmacia, Sweden) as described in detail in our previous 
studies[22].  Briefly the gel was photographed under UV 
transillumination. The intensity of  PCR products was 
measured using video image analysis system (Kodak Digital 
Science).  The SOD mRNA signals were standardized against 
the β-actin mRNA signal for each sample and results were 
expressed as SOD mRNA/β-actin mRNA ratio.
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caused a signif icant attenuation of  WRS-induced 
gastric damage; the ID50 being 36 mg/kg. The GBF was 
significantly decreased in rats exposed to 3.5 h of  WRS 
but GSE given 30 min before the exposure of  animals to
3.5 h of  WRS resulted in a dose-dependent rise in the 
GBF as compared to that obtained in vehicle-treated 
animals (Figure 2).
Effect of pretreatment with GSE on the gastric mucosal 
SOD activity and MDA content in gastric mucosa exposed 
to ethanol or WRS
Tab le 2 shows the resu l t s o f  de te r mina t ion of  
MDA+4 HNE as an index of  lipid peroxidation in the 
gastric mucosa or rats exposed to ethanol- or WRS without 
or with GSE pretreatment.  The MDA concentration was 
significantly increased in vehicle-control gastric mucosa 
exposed to ethanol or WRS as compared to that in the 
intact gastric mucosa. Pretreatment with GSE applied ig 
Statistical analysis
Results are expressed as means±SE.  The significance of  
the difference between means was evaluated using analysis 
of  variance followed by Duncan’s test with a level of  
significance at P < 0.05.
RESULTS 
Effect of GSE on gastric acid secretion and plasma 
gastrin levels in rats with chronic GF 
As shown in Table 1, gastric acid output reached the value 
of  134±11 μmol/30 min, while fasting plasma gastrin 
concentration averaged of  53 ± 4  μmol/L in control rats 
treated with vehicle (saline). GSE applied ig in a dose of  
8 mg/kg ig failed to affect significantly the gastric acid 
output and plasma gastrin levels as compared to those in 
control animals. GSE applied ig in a dose of  16 mg/kg 
and higher, produced a significant decrease in the gastric 
acid output and significantly raised the plasma gastrin 
levels (Table 1).    
Effect of GSE on acute gastric lesions induced by ethanol 
and WRS 
Figure 1 shows the effect of  topical pretreatment with 
GSE applied ig in graded concentrations ranging from 8 to 
64 mg/kg on the mean area of  gastric lesions induced by 
100% ethanol and the accompanying changes in the GBF. 
Ethanol caused typical widespread gastric lesions with an 
area of  86±5 mm2 and reduced the GBF by about 38% as 
compared to that in intact gastric mucosa.  Pretreatment 
with GSE applied in the lowest dose of  8 mg/kg, failed 
to influence the ethanol lesions but starting from the 
dose 16 mg/kg up to dose of  64 mg/kg of  GSE, a dose-
dependent reduction in gastric lesions was observed; the 
dose that inhibits ethanol damage by 50% (ID50) being 28 
mg/kg. This protective effect of  GSE applied in graded 
doses against ethanol damage was accompanied by the 
significant rise in the GBF. The gastroprotective effect of  
GSE and accompanying increase in the GBF were similar 
to those achieved by the pretreatment with methyl analog 
of  PGE2 applied 30 min before the application of  ethanol. 
As shown in Figure 2, the pretreatment with GSE 
applied topically in a doses ranging from 8 to 64 mg/kg
Table 1 Effect of vehicle (saline) and GSE applied ig in graded 
concentrations ranging from 8 up to 64 mg/kg on the gastric acid 
secretion and plasma gastrin levels. Results are mean±SE from 6 
determinations on 6–8 animals               
 Type of test                                   Gastric acid output                                Plasma gastrin 
                                                              (μmol/30 min)                                        (pmol/L)
Vehicle                                          134 ± 11                                                  53 ± 4
GSE (mg/kg ig)
8                                                     131 ± 9                                                    56 ± 6
16                                                   118 ± 9a                                                   69 ± 8a
32                                                     89 ±7a                                                   75 ± 9a
64                                                     64 ± 5a                                                   82 ± 10a
　　　　　　　　　　 












































Figure 1 Effect of intragastric (ig) pretreatment with GSE applied in graded doses 
ranging from 8 mg/kg up to 64 mg/kg or 16,16 dimethyl PGE2 (5 μg/kg ig) on the 
mean area of gastric lesions induced by ethanol and accompanying changes 
in the GBF. Results are mean±SE from 6 to 8 animals per group. aP<0.05 vs 
vehicle (Veh).  
Figure 2 Effect of intragastric (ig) pretreatment with GSE applied in graded doses 
ranging from 8 mg/kg up to 64 mg/kg or 16,16 dimethyl PGE2 (5 μg/kg ig) on the 
mean number of gastric lesions induced by 3.5 h of WRS and accompanying 
changes in the GBF. Results are mean ± SE from 6 to 8 animals per group. 
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Effect of inhibitors of COX and NOS activity on GSE-
induced gastroprotection against WRS induced gastric 
damage and the alterations in GBF
Pretreatment with GSE (32 mg/kg ig) significantly 
reduced gastric lesions induced by WRS in a manner 
similar to that presented in Figure 2. The ip administration 
of  indomethacin at a dose of  5 mg/kg which inhibited 
generat ion of  endogenous PGE 2 by about 85%, 
ag g ravated the WRS-induced gastr ic les ions and 
significantly decreased GBF as compared to the respective 
values in animals treated with vehicle. Such pretreatment 
with indomethacin reversed almost completely the 
protective effect of  GSE against WRS-induced lesions and 
the accompanying increase in the GBF (Figure 3).  
The L-NNA, an inhibitor of  NO-synthase by itself  
failed to affect the area of  gastric lesions and the fall in 
the GBF induced by ethanol or WRS (Table 3, Figure 4).
Pretreatment with GSE (32 mg/ kg ig) resulted in a 
significant reduction of  ethanol- or WRS-induced gastric 
damage and significantly decreased the GBF as compared 
with the respective values attained in rats without GSE 
administration. Co-treatment with L-arginine (200 mg/kg 
ig) but not with D-arginine, added to GSE restored the 
gastroprotection and the accompanying increase in the 
Table 3  Effect of GSE with or without pretreatment with NG-
nitro-L-arginine (L-NNA 20 mg/kg ip) applied with or without the 
combination with L-arginine (L-Arg, 200 mg/kg ig) or D-arginine 
(D-Arg, 200 mg/kg ig) on the area of ethanol-induced gastric 
lesions and accompanying changes in the GBF. Results are mean±
SE of 6–8 rats
aP < 0.05 vs vehicle, cP < 0.05 vs values in respective group without L-NNA, 
eP < 0.05 vs values in respective group with L-NNA but without L-Arg 
administration.
Type of test                            Mean lesion area  (mm2)                           GBF (% control) 
Without L-NNA 
Vehicle                                        82 ± 5                                                     63 ± 3
GSE  (32 mg/kg i.g.)                  8 ± 1.5a                                                 81 ± 4a
With L-NNA
Vehicle                                        88 ± 4                                                     58 ± 3
GSE (32 mg/kg i.g.)                  76±3c                                                     66 ± 5c
L-Arg (200 mg/kg i.g.) 
       +GSE (32 mg/kg i.g.)        12 ± 2c                                                     79 ± 3c
D-Arg (200 mg/kg i.g.) 
       +GSE (32 mg/kg i.g.)        72 ± 4                                                      69 ± 3 
     　　　　　　　　　                 
Table 4 The number of WRS-induced gastric lesions and 
accompanying changes in the GBF in rats treated with vehicle and 
GSE  (32 mg/kg i.g.) without or with capsaicin denervation. Means
±SE of 6–8 rats
aP < 0.05 vs vehicle,  cP < 0.05 vs corresponding values obtained in animals 
without capsaicin denervation, eP < 0.05 vs corresponding values obtained in 
animals with capsaicin denervation without CGRP treatment.  
Type of test                              Mean lesion number                                 GBF (% control)  
3
Without capsaicin denervation 
Vehicle                                            18 ± 3                                                   67 ± 4
GSE  (32 mg/kg ig)                         8 ± 1.5a                                               78 ± 3a
With capsaicin denervation
Vehicle                                            28 ± 4b                                                   54 ± 3b  
GSE (32 mg/kg ig)                        16 ± 3b                                                   64 ± 4b  
CGRP (10 μg/kg sc) 
       +GSE (32 mg/kg ig)                9 ± 1.3c                                                 74 ± 3c  
     　　　　             　　　　　　      
in a dose 16 mg/kg or higher, significantly attenuated the 
MDA concentration in animals exposed to ethanol or WRS 
(Table 2). The mucosal SOD activity was inhibited in the 
gastric mucosa of  animals exposed to ethanol or WRS as 
compared to the respective value in intact gastric mucosa 
(Table 2).  In contrast, the pretreatment with GSE applied 
in i.g. in graded doses ranging from 8 up to 64 mg/kg,
which caused a significant attenuation of  the damage 
induced by ethanol or WRS, dose-dependently reversed the 
deleterious effect of  ethanol or WRS on the SOD activity 
and significantly counteracted the ethanol and WRS-
induced rise in the MDA content (Table 2).  
Table 2  Effect of vehicle (saline) and GSE applied i.g. in graded 
concentrations ranging from 8 mg/kg up to 64 mg/kg on the MDA 
concentration and SOD activity in the gastric mucosa in rats 
exposed to 100% ethanol or those subjected to 3.5 h of WRS. 
Results are mean±SE from 6 determinations on 6–8 animals
aP < 0.05 vs intact, cP < 0.05 vs vehicle+ethanol or vehicle+WRS.
Type of test                                     MDA concentration                              SOD activity  
                                                                     (nmol/g)                                              (unit/g)
Intact                                                  0.5 ± 0.02                                          733 ± 43     
Vehicle+ethanol                             14.8  ± 2.3a                                          425 ± 32a
Vehicle+WRS                                  16.8 ± 2.3a                                          425 ± 32a
GSE (mg/kg i.g.)+ethanol
8                                                        13.7 ± 2.3                                           438 ± 37
16                                                       10.4 ± 2.8c                                          549 ± 38c
32                                                        8.3 ± 0.9c                                           675 ± 40c
64                                                        6.6 ± 0.7c                                           695 ± 43c 
GSE (mg/kg i.g.)+WRS    
8                                                         15.7 ± 2.6c                                          438 ± 37c
16                                                       13.4 ± 2.3c                                          549 ± 38c
32                                                       10.3 ± 1.9c                                          675 ± 40c
64                                                         8.6 ± 0.8c                                           695 ± 43c  
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GBF induced by this extract in L-NNA treated animals. 
Capsaicin-denervation which by themselves aggravated 
ethanol- and WRS-induced gastric damage significantly 
attenuated the GSE-induced protection and hyperemia 
against lesions induced by ethanol or WRS (Table 4, 
Figure 5).  Co-administrat ion of  calcitonine gene-
related peptide (CGRP) with GSE in rats with capsaicin-
denervation restored the protective and hyperemic effects 
of  this extract against ethanol- and WRS-induced gastric 
lesions. 
Gastric mucosal expression of mRNA for SOD in ethanol-
treated rats with or without pretreatment with GSE 
As shown in Figure 6, mRNA for SOD was detected by 
RT-PCR as a strong signal in the gastric mucosa of  vehicle-
control animal not treated with ethanol. In contrast, the 
signal for the SOD mRNA in the gastric mucosa of  
ethanol-treated rats was faint. The ratio of  SOD mRNA 
Figure 3  Effect of GSE (32 mg/kg ig) on the mean number of WRS-induced 
gastric lesions and accompanying alterations in the gastric mucosal PGE2 
generation and GBF in rats with or without the pretreatment with indomethacin 
(5mg/kg ip) or rofecoxib (10 mg/kg ig).  Results are mean±SE from 6 to 8 animals 
per group. aP<0.05 vs vehicle (Veh), cP<0.05 vs respective values in animals 
without indomethacin or rofecoxib pretreatment.  
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Figure 4  Effect of GSE (32 mg/kg i.g.) on the mean number of WRS-induced 
gastric lesions and accompanying alterations in the GBF in rats with or without the 
pretreatment with L-NNA (20 mg/kg i.p.).  Results are mean ±SE from 6-8 animals 
per group. aP < 0.05 vs vehicle (Veh), bP < 0.01 vs respective values in animals 
without L-NNA administration, cP < 0.05 vs respective values in animals treated 
with L-NNA.  vs vehicle (Veh), bP < 0.01 vs respective values in animals without 



























































Figure 5  Effect of GSE (32 mg/kg ig) on the mean area of ethanol-induced gastric 
lesions and accompanying alterations in the GBF in rats with or without capsaicin 
inactivation of sensory nerves.  Results are mean±SE from 6–8 animals per 
group. aP < 0.05 vs vehicle (Veh), bP < 0.01 vs respective values in animals without 
capsaicin denervation, cP < 0.05 vs respective values in animals with capsaicin 
denervation.  administration, cP < 0.05 vs respective values in animals treated 
with L-NNA.  vs vehicle (Veh), bP < 0.01 vs respective values in animals without 
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over β-actin mRNA was significantly decreased in ethanol-
treated animals as compared to those treated with vehicle 
only.  SOD mRNA was strongly expressed in animals 
pretreated with various doses of  GSE (16-64 mg/kg ig) 
before the ethanol application. The ratio of  mRNA for 
SOD over the β-actin mRNA was significantly increased 
in gastric mucosa of  rats pretreated with graded doses of  
GSE as compared to that attained in vehicle-pretreated 
rats that were given ethanol.    
 DISCUSSION
This study shows that GSE attenuates the lesions in the rat 
stomach by the intragastric application of  noxious agent 
such as ethanol or those caused by stress and that this 
protective effect of  GSE is accompanied by the increase 
in the GBF and SOD expression and its activity and 
reduction of  MDA concentration, that is widely considered 
as an index of  lipid peroxidation.  The inhibition of  acid-
dependent lesions caused by WRS can be attributed to the 
inhibition of  acid secretion by this compound as observed 
in this study using well-conditioned and fully adapted GF 
rats. This protective and hyperemic activity of  GSE against 
WRS ulcerogenesis was abolished by COX inhibitors such 
as indomethacin and rofecoxib and significantly reduced 
by L-NNA.  Thus, we conclude that GSE containing 
citrous flavonoids exerts a potent gastroprotective activity 
against ethanol- and WRS-induced gastric lesions and this 
protective effect in the stomach may involve endogenous 
PG derived from COX-1 and COX-2 activity, suppression 
of  lipid peroxidation and gastric hyperemia mediated by 
NO and neuropeptides released from afferent sensory 
nerves.   
Previous studies documented that grapefruit seeds are 
the major depository for limonoids (triterpenoid dilactones 
chemically related to limonin) of  these 77% are neutral 
while 2% are acidic limonoids[1-3].  Grapefruit contains 
also many flavonoids that includes glycosides, naringenin, 
quercetin, kaempferol, hesperetin and apigenin being the 
most abundant among their aglycones[4]. GSE, containing 
flavonoids, has been shown to possess antibacterial, 
antiviral and antifungal properties[2,3]. This beneficial 
action of  GSE was attributed to the antioxidative activity 
of  grapefruit containing citrus flavonoids[4,23], since, for 


























Figure 6 Determination of SOD mRNA (left panel) by RT-PCR and by ratio of SOD mRNA over β-actin (right panel) in the vehicle-control intact gastric mucosa (lane 1) and 
in those treated with GSE given i.g. in graded doses of 16 mg/kg (lane 2), 32 mg/kg (lane 3) and 64 mg/kg (lane 4) prior to the exposure to ethanol, M-DNA size marker, NC-
negative control. Mean±SE of 4–6 rats. aP < 0.05 vs vehicle (Veh), bP < 0.01 vs ethanol alone group. cP < 0.05 vs respective values in animals with capsaicin denervation. 
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anti-H pylori activity in vitro[5,24].  Furthermore, grapefruit 
containing flavonoids were also recently implicated in 
cytoprotection against injury induced by algal toxins 
in isolated hepatocytes[6,25].  Interestingly, GSE in a 
formulation of  Citricidal, was demonstrated to be effective 
against more than 800 bacterial and vital strains, 100 strains 
of  fungus and a large number of  single or multicelled 
parasites[1]. These antimicrobiological properties against 
a wide range of  Gram-negative and Gram-positive 
organisms were attributed to the disruption by GSE of  
the bacterial membrane and the subsequent liberation by 
this extract of  the bacterial cytoplasmic contents within a 
relatively short time  (e.g. 15-20 min).  In a similar report, 
it was reported that GSE-induced antimicrobial action is 
comparable to that of  proven antibacterials[2].  Moreover, 
naringenin, the bioactive component of  GSE, showed 
anti-cancer activity against human breast cancers[7,26]. The 
underlying mechanism of  the therapeutic efficacy of  citrus 
fruits such as grapefruits and red grapes seems to depend 
upon the presence of  different classes of  polyphenolic 
flavonoids that were shown to inhibit platelet aggregation, 
thus decreasing the risk of  coronary thrombosis and 
myocardial infarction[27-30]. 
The involvement of  GSE in the mechanism of  gastric 
mucosal defense against the formation of  gastric lesions 
caused by obnoxious substances has been little studied. 
Herein, we provide evidence that GSE applied topically 
caused dose-dependent diminution of  acute gastric lesions 
induced by both, 100% ethanol and WRS.  Previous 
studies  demonstrated that the damaging action of  
ethanol and WRS could be attributed to the enhancement 
in the reactive oxygen substances (ROS) and the ROS-
dependent increase in the lipid peroxidation and inhibition 
of  antioxidizing enzyme activity[18,19,21].  We found that 
GSE dose-dependently attenuated the rise in MDA 
content in the gastric mucosa injured by ethanol 
or WRS indicating that this extract can attenuate 
the process of  lipid peroxidation implicated in the 
pathogenesis of  ethanol and WRS-induced gastric 
damage[18,19].  Moreover, we have demonstrated that 
ethanol decreased the gene expression and activity 
of  SOD in the gastric mucosa suggesting that the 
suppression of  key mucosal antioxidizing enzyme 
along with the elevation of  lipid peroxidation, play an 
important role in the pathogenesis of  these lesions. 
This increase in the mucosal lipid peroxidation as well 
as the fall in SOD expression and its activities were 
attenuated by GSE, suggesting that the reduction in 
lipid peroxidation by this seed extract may contribute 
to the attenuation of  the deleterious effect of  noxious 
agents on the gastric mucosa. This is supported by 
the fact that the GBF was elevated and gastric PGE2 
production were enhanced in animals treated with 
GSE as compared to those treated with vehicle. Our 
finding is in accordance with observations that some 
flavonoids stimulated PGE2 production by isolated 
gastric mucosal cells while suppressing gastric acid 
secretion via direct inhibitory effect on H+/K+-
ATPase activity[24].  It is not concluded that NO/NOS 
system is also involved in gastroprotection against 
ethanol and WRS caused by GSE because both, GSE-
induced protection and hyperemia were counteracted 
by L-NNA, a non-specific inhibitor of  NO-synthase 
and this effect was restored in these animals by the 
combined treatment with L-arginine and GSE.  Thus, 
our study implies that some natural products of  the 
citrous fruits such as GSE, afford protection against 
ethanol and stress-induced gastric damage due to 
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endogenous PG and the preservation of  expression and 
activity of  a major antioxidizing enzyme such as SOD. 
The mechanism of  gastroprotective activity of  GSE 
appears to be dependent on endogenous PG and the 
functional activity of  sensory nerves releasing CGRP. This 
notion is supported by our findings that indomethacin, a 
non-selective inhibitor of  COX-1 and COX-2 activity or 
functional ablation of  sensory afferent nerves by capsaicin 
reversed GSE-induced protection and accompanying 
hyperemia. In addition, co-treatment of  exogenous 
CGRP with GSE, administered to replace the deficit of  
this peptide in capsaicin-treated animals, restored the 
protective efficacy of  GSE.  Interestingly, rofecoxib which 
is a highly selective COX-2 inhibitor[17], also attenuated 
the gastroprotective and hyperemic activities of  GSE 
suggesting the involvement of  COX-2 derived products 
in the gastroprotection and increase in the GBF induced 
by this extract.  Further studies assessing the mRNA 
expression of  COX-1 and COX-2 in GSE-treated mucosa 
should reveal which enzymatic pathway is involved in 
aforementioned effects of  this extract. 
This gastroprotective activity of  the GSE could be 
attributed to naringenin, a major GSE flavonoid, because 
this flavonoid was reported to exhibit gastroprotection 
against the gastric injury induced by absolute ethanol, 
predominant ly due to the increase in the mucus 
secretion[10].  It is of  interest that this gastroprotective 
effect of  naringenin and accompanying increase in the 
mucus secretion, were, in part, attenuated by indomethacin, 
supporting the contribution of  endogenous PG to the 
mechanism of  gastroprotection by grapefruit products[10]. 
As shown in our present study, GSE by itself  enhanced the 
gastric mucosa generation of  PGE2 but our unpublished 
evidence indicates that this extract can be also effective 
against aspirin-induced gastric lesions under the conditions, 
where PG generation is completely suppressed. Therefore, 
it seems likely, that endogenous PG might not be primary 
mediators of  this protection and other gastroprotective 
factors such as NO and/or neuropeptides released from 
sensory afferent nerves could be involved.  This was the 
reason for carrying out the study with L-NNA, a potent 
NO-synthase inhibitor and with capsaicin, applied in a 
dose that causes functional ablation of  sensory nerves 
releasing vasoactive neuropeptides such as CGRP.  We 
found that L-NNA and capsaicin denervation inhibited 
the GSE-induced protection against ethanol- and WRS-
induced gastr ic lesions and accompanying gastr ic 
mucosal hyperemia. Our study militates against PG as 
the primary mediator in the mechanism of  GSE-induced 
gastroprotection and this remains in accordance with our 
previous report that meciadanol, the synthetic flavonoid 
inhibiting the activity of  HDC, prevented the ethanol- and 
aspirin-induced injury in rat stomach without altering the 
mucosal generation of  prostacyclin (PGI2)[9]. 
Another candidate involved in the GSE-induced 
protection could be gastrin, which is known to exhibit 
both, gastroprotective and hyperemic activities[11]. Indeed, 
we addressed this issue by direct determination of  the 
plasma gastrin levels by specific RIA and we found that 
gastrin is elevated in GSE-treated animals.  This effect 
could be secondary to the inhibition of  gastric acid 
secretion caused by this compound as demonstrated in 
our study by the administration of  GSE to the chronic, 
well-adapted rats with chronic GF. Suppression of  gastric 
secretion by GSE might contribute to the protective 
activity of  this extract against WRS, because WRS damage 
depends upon gastric acidity and becomes exaggerated by 
acidic conditions in the stomach.
In summary, we have demonstrated in this report that 
the pretreatment with GSE reduces the ethanol and WRS-
induced gastric damage through the preservation of  the 
antioxidizing enzyme (SOD) activity, reduction of  free 
radical-dependent lipid peroxidation, enhancement in the 
GBF and plasma gastrin levels. Endogenous PG appears 
to be important mediator of  this protection, but other 
mediators such as NO and neuropeptides released from 
sensory nerves such as CGRP could be also involved 
in the gastroprotective and hyperemic activities of  this 
extract. No study, so far has been undertaken to examine 
the ulcer healing efficacy of  GSE, but the fact that this 
grapefruit seed extract exerts a potent anti-H pylori in 
vitro[30] and profound gastroprotective effects in laboratory 
animals warrants a further approach for its potential 
application in healing of  chronic ulcerations in human 
beings.  
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